The Guidance of Thin Cross- Section of CT in Anatomic Segmentectomy

The Guidance of Thin Cross- Section of CT in Anatomic Segmentectomy With or Without 3-dimensional Computed Tomography Lung Simulation

Three-dimensional (3D) simulation of pulmonary vessels and the space between the lesion and adjacent tissues is regarded improving the safety and accuracy of video-assisted thoracoscopic surgery (VATS) for segmentectomy for ground glass opacity (GGO) in lung. However, not every thoracic surgeon can handle the technique, in addition, the 3D reconstruction originate from the thin CT scan. Actually, the investigators found that, the reading and comprehension of the thin cross- section of CT can guide the accurate anatomic segmentectomy in most situations. The investigators designed a retrospective study to compare the reading of thin cross- section of CT with 3D reconstruction or without 3D reconstruction during the guidance of anatomic segmentectomy.

Study Overview

Study Type

Interventional

Enrollment (Actual)

200

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Shandong
      • Jinan, Shandong, China, 250033
        • The Second Hospital of Shandong University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

25 years to 85 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

Selection criteria for VATS segmentectomy in the present study were as follows:

(I) patients with single peripheral GGO lesion considered suspicious for malignancy;

(II) the lesion <2 cm in diameter and with at least one of the followings:

(i) pure adenocarcinoma in situ (AIS) histology;

(ii) nodule has ≥50% ground-glass appearance on high resolution CT;

(iii) radiologic surveillance conforms a long doubling time (≥400 days).

Exclusion Criteria:

(I) patients with insufficient cardiopulmonary function;

(II) other contraindication for segmentectomy.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Non-Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: group of thin cross- section of CT
Anatomic Segmentectomy with the Guidance of Thin Cross- Section of CT
The anatomic segmentectomy is base on the reading and comprehension of Cross- Section of CT.
Active Comparator: group of thin 3D simulation
Anatomic Segmentectomy with the Guidance of 3D simulation
The anatomic segmentectomy is base on the overview of 3D simulation of pulmonary structure.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
planning time (minutes)
Time Frame: from the first time of thin cross- section of CT is presented to the end of surgery, within 7 days
the planning time for anatomic segmentectomy before surgery, including the time- cost of the decision making and the planning time for surgery
from the first time of thin cross- section of CT is presented to the end of surgery, within 7 days
time before surgery (days)
Time Frame: from the day of being hospitalized to the day of surgery, within 5 days
days before surgery after being hospitalized
from the day of being hospitalized to the day of surgery, within 5 days
operation time (minutes)
Time Frame: from beginning to the end of surgery, up to 180 minutes
the duration of the operation time
from beginning to the end of surgery, up to 180 minutes
confirmation time during surgery (number)
Time Frame: Intraoperative
review time of the 3D reconstruction or the thin cross- section of CT during surgery
Intraoperative
air leakage after surgery (days)
Time Frame: within 7 days after surgery
the days of air leakage after surgery
within 7 days after surgery
the incidence of pneumonia (percentage)
Time Frame: within 7 days after surgery
the incidence of pneumonia after surgery
within 7 days after surgery
the incidence of atelectasis (percentage)
Time Frame: within 7 days after surgery
the incidence of atelectasis after surgery
within 7 days after surgery
Intraoperative bleeding (ml)
Time Frame: Intraoperative
bleeding during anatomic segmentectomy, through the operation, an average of 100 ml
Intraoperative
Chest tube duration (days)
Time Frame: within 7 days after surgery
Chest tube duration after surgery
within 7 days after surgery
Postoperative hospital stay (days)
Time Frame: within 7 days after surgery
hospital stay after surgery
within 7 days after surgery

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Xiaogang Zhao, The Second Hospital of Shandong University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

March 30, 2021

Study Completion (Actual)

March 30, 2021

Study Registration Dates

First Submitted

April 3, 2021

First Submitted That Met QC Criteria

April 12, 2021

First Posted (Actual)

April 13, 2021

Study Record Updates

Last Update Posted (Actual)

April 13, 2021

Last Update Submitted That Met QC Criteria

April 12, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • thin cross- section of CT ZYP

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Segmentectomy

Clinical Trials on Cross- Section of CT Guided Anatomic Segmentectomy

Subscribe